// App-Quantinova.ai

e13057 : Second malignant neoplasm (SMN) in a cohort of early stage cancer survivors (ESCS) followed at Instituto Oncologico Henry Moore (IOHM) in the last 15 years.

Researchers

Presenter

  • Flavio Tognelli

Principal Investigators

  • Ernesto Gil Deza

  • Natasha Gercovich

  • Eduardo L. Morgenfeld

  • Edgardo G. J. Rivarola

  • Claudia Lorena Acuna

  • Dario Niewiadomski

  • Felipe G. Gercovich

Medical Centers

  • Instituto Henry Moore, Buenos Aires, Argentina

  • Instituto Henry Moore, Capital Federal, Buenos Aires, Argentina

  • Instituto Henry Moore, Capital Federal, Buenos Aires, Argentina

  • Instituto Henry Moore, Capital Federal, Buenos Aires, Argentina

  • Instituto Henry Moore, Capital Federal, Buenos Aires, Argentina

  • Henry Moore, Capital Federal, Argentina

Locations

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Ophthalmology (OP)

Disease

  • Solid malignancies

  • Enhanced S cone syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final